Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1187189

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Sleeping Rough
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to support rough sleepers with (a) drug and alcohol addiction and (b) mental health problems.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	33687
answer	answer is ministerial correction date of answer 31/03/2020 answer text <p>The Government recognises that many people who are sleeping rough have mental health issues and suffer disproportionate harms from drugs and alcohol misuse. The Government has committed to end rough sleeping by the end of this term of Parliament.</p><p>To support this commitment the Government has announced £262 million of funding over four years for substance misuse treatment and recovery services for people experiencing rough sleeping or at risk of rough sleeping.</p><p>Guidance to support commissioners and providers of services for people who use drugs and alcohol during the COVID-19 pandemic is being developed and will be issued shortly.</p><p>The Department is also providing £2 million in funding to test ways to improve access to health services for people with co-occurring mental ill-health and substance misuse problems who are currently, or at risk of returning to, sleeping rough. This builds on the commitment already made in the NHS Long Term Plan to spend up to £30 million over five years on mental health services for rough sleepers.</p><p><strong> </strong></p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 31/03/2020 12:40:34 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4412 label Biography information for Dr Lisa Cameron

1187191

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Mental Health Services: Sleeping Rough
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will update the Rough Sleeping Strategy to include further provisions for mental health support for rough sleepers.
tabling member constituency	East Kilbride, Strathaven and Lesmahagow
tabling member printed	Dr Lisa Cameron
uin	33689
answer	answer is ministerial correction date of answer 31/03/2020 answer text <p>As a part of the NHS Long Term Plan, NHS England has committed to spending up to £30 million over five years on mental health services for rough sleepers, to ensure that the parts of England most affected by rough sleeping will have better access to specialist homelessness National Health Service mental health support, integrated with existing outreach services.</p><p>We are also providing £2 million in funding to test ways to improve access to health services for people with co-occurring mental ill-health and substance misuse problems who are currently, or at risk of returning to, sleeping rough.</p><p>The Government has announced £262 million of funding over four years for substance misuse treatment and recovery services for people experiencing rough sleeping or at risk of rough sleeping. Urgent access to mental health services will be an integral part of this approach, as many rough sleepers have both mental health and substance misuse needs.</p><p> </p> answering member constituency Mid Bedfordshire answering member printed Ms Nadine Dorries question first answered 31/03/2020 12:40:53 answering member 1481 label Biography information for Ms Nadine Dorries
tabling member	4412 label Biography information for Dr Lisa Cameron

1187302

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Hospitals
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what additional funding has been allocated to (a) Chase Farm Hospital, (b) North Middlesex Hospital and (c) Enfield Public Health to deal with the covid-19 outbreak.
tabling member constituency	Enfield North
tabling member printed	Feryal Clark
uin	33748
answer	answer is ministerial correction date of answer 31/03/2020 answer text <p>The Government has taken unprecedented actions to deal with the costs of the COVID-19 outbreak. The Chancellor of the Exchequer announced on 11 March a £5 billion “emergency response fund” for the National Health Service and other public services.</p><p>NHS England and NHS Improvement will be responsible for ensuring this money gets to the frontline providers that need it.</p><p> </p><p> </p> answering member constituency Charnwood answering member printed Edward Argar question first answered 31/03/2020 11:22:44 answering member 4362 label Biography information for Edward Argar
tabling member	4822 label Biography information for Feryal Clark

1187330

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	IVF
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, further to the Written Answers by Baroness Blackwood of North Oxford on 20 January (HL277) and Lord Bethell on 5 March (HL1701) and 18 March (HL2406), what outcomes the Human Fertilisation and Embryology Authority consider to be adverse following mitochondrial donation treatment; whether such outcomes include (1) implantation failure, (2) spontaneous miscarriage, and (3) the termination of a pregnancy following the detection of unanticipated abnormalities; and what assessment they have made of the reason for the lack of live births pursuant to the application of such treatments.
tabling member printed	Lord Alton of Liverpool
uin	HL2792
answer	answer is ministerial correction date of answer 02/04/2020 answer text <p>The Human Fertilisation and Embryology Authority (HFEA) have advised that this information is set out in its Code of Practice at section 33.35, which states:</p><p>“If a centre becomes aware that a child born following mitochondrial donation has been born with a mitochondrial disease, birth defect, or genetic abnormality, or if there has been some other adverse outcome (including but not limited to failed or no embryo development, miscarriage or premature birth) following treatment involving mitochondrial donation, the centre must regard this as an adverse incident and report this to the HFEA in line with the requirements on adverse incidents set out in guidance note 27. This is to capture information about any abnormalities that may occur as a result of carrying out the MST (maternal spindle transfer) or PNT (pro-nuclear transfer) treatment, to inform any regulatory or licensing action that the HFEA may wish to take and to inform the scientific sector.”</p><p>The HFEA has made no assessment of the efficacy of mitochondrial treatment to date as the number of treatments is so low, at this stage.</p> answering member printed Lord Bethell question first answered 02/04/2020 15:22:58 answering member 4708 label Biography information for Lord Bethell
tabling member	738 label Biography information for Lord Alton of Liverpool

1187332

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Hydroxychloroquine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of reports about the success of using hydroxychloroquine to treat COVID-19, following a study carried out by Professor Raoult, director of the Institut Hospitalo-Universitaire de Marseille.
tabling member printed	Lord Alton of Liverpool
uin	HL2794
answer	answer is ministerial correction date of answer 02/04/2020 answer text <p>The Department is considering carefully all available evidence around the potential of different medicines for use in treating COVID-19. Clinical trials are ongoing and being developed to assess the benefits of a number of different medicines in treating COVID-19.</p><p>Hydroxychloroquine is not currently licensed to treat COVID-19 related symptoms or prevent infection. Clinical trials are being established to test hydroxychloroquine as an agent in the treatment of COVID-19. These clinical trials are still not completed, so no conclusions have yet been reached on the safety and effectiveness of this medicine to treat or prevent COVID-19.</p> answering member printed Lord Bethell question first answered 02/04/2020 15:23:39 answering member 4708 label Biography information for Lord Bethell
tabling member	738 label Biography information for Lord Alton of Liverpool

1187333

registered interest
date	23/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government, following their decision to ban the parallel export of drugs used to treat malaria and HIV, whether UK stocks of such medicines are being trialled for use on patients with COVID-19; and if so, what (1) clinical evidence has been gathered, and (2) conclusions have been reached, about the efficacy of such treatment.
tabling member printed	Lord Alton of Liverpool
uin	HL2795
answer	answer is ministerial correction date of answer 02/04/2020 answer text <p>United Kingdom stocks of medicines to treat malaria and HIV are being trialled for use on patients with COVID-19.</p><p>There are suggestions in the Chinese and French literature that both lopinavir/ritonavir and chloroquine/hydroxychloroquine may be beneficial. However, these data are not conclusive, because the studies done are too small, thus the findings, whilst promising, may ultimately be wrong.</p><p>The UK will evaluate both these treatments in two large randomised trials, one of which is already underway and the other of which is expected to begin recruitment next week.</p> answering member printed Lord Bethell question first answered 02/04/2020 15:31:42 answering member 4708 label Biography information for Lord Bethell
tabling member	738 label Biography information for Lord Alton of Liverpool

1186794

registered interest
date	20/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Sick Leave
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS workers returning to work will be subject to an interview after seven days absence in line with routine process or whether that requirement will be relaxed during the covid-19 pandemic.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	32642
answer	answer is ministerial correction date of answer 27/03/2020 answer text <p>National Health Service employers are responsible for managing sickness absence in their organisation and it will be up to each individual employer to decide whether they continue with return to work interviews or decide to relax the process during the COVID-19 pandemic.</p><p>The Department continues to commission NHS Employers to provide guidance, advice and resources for NHS trusts to manage sickness absence. A toolkit specifically designed to manage sickness absence can be found at the following link:</p><p><a href="https://www.nhsemployers.org/retention-and-staff-experience/health-and-wellbeing/action-on-sickness-absence" target="_blank">https://www.nhsemployers.org/retention-and-staff-experience/health-and-wellbeing/action-on-sickness-absence</a></p><p>NHS organisations need to take a collaborative approach to supporting staff and this includes closer working with occupational health providers who can provide proactive support and guidance to staff who may be more vulnerable to COVID-19.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/03/2020 13:19:48 answering member 4527 label Biography information for Helen Whately
tabling member	1438 label Biography information for Mr Kevan Jones

1186823

registered interest
date	20/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Drugs: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure supply of generic drugs and repeat prescriptions of (a) paracetamol, (b) thyroxine, (c) warfarin and (d) insulin during the covid-19 outbreak.
tabling member constituency	Putney
tabling member printed	Fleur Anderson
uin	32737
answer	answer is ministerial correction date of answer 25/03/2020 answer text <p>The country is well prepared to deal with any impacts of COVID-19 and we have stockpiles of generic drugs, in the event of any supply issues or significant increases in demand.</p><p>The Department is working closely with industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need, and precautions are in place to reduce the likelihood of future shortages.</p><p>The steps being taken to protect United Kingdom supplies in response to the COVID-19 outbreak were set out in the Department’s press statement issued on 11 February 2020. This statement can be read at the following link:</p><p><a href="https://www.gov.uk/government/news/government-to-monitor-impact-of-coronavirus-on-uk-medicine-supply" target="_blank">https://www.gov.uk/government/news/government-to-monitor-impact-of-coronavirus-on-uk-medicine-supply</a></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/03/2020 16:55:28 answering member 4380 label Biography information for Jo Churchill
tabling member	4788 label Biography information for Fleur Anderson

1186434

registered interest
date	19/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	MMR Vaccine
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps is he taking to improve take-up of the MMR vaccine for five year old children.
tabling member constituency	East Londonderry
tabling member printed	Mr Gregory Campbell
uin	32069
answer	answer is ministerial correction date of answer 25/03/2020 answer text <p>To increase take-up of the measles, mumps and rubella (MMR) vaccine, NHS England and NHS Improvement and Public Health England are working with key regional and local stakeholders, such as Directors of clinical quality, clinical commissioning groups and local authorities, to implement actions from Public Health England’s ‘Measles and rubella UK elimination strategy 2019’. The actions include notifications from Child Health Information Services to help general practices identify children with due and overdue vaccinations and improving information to parents that emphasises the importance getting the MMR vaccination.</p><p> </p><p> </p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 25/03/2020 16:02:45 answering member 4380 label Biography information for Jo Churchill previous answer version 14526 answering member constituency Bury St Edmunds answering member printed Jo Churchill answering member 4380 label Biography information for Jo Churchill
tabling member	1409 label Biography information for Mr Gregory Campbell

1186460

registered interest
date	19/03/2020
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Abortion
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, how many abortions were performed after 24 weeks in (a) 2017, (b) 2018, and (c) 2019.
tabling member constituency	Congleton
tabling member printed	Fiona Bruce
uin	32115
answer	answer is ministerial correction date of answer 27/03/2020 answer text <p>Abortion statistics for 2017 and 2018 are available at the following links:</p><p><a href="https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2018%20" target="_blank">https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2018</a></p><p> </p><p><a href="https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2017" target="_blank">https://www.gov.uk/government/statistics/abortion-statistics-for-england-and-wales-2017</a></p><p>The number of legal abortions performed after 24 weeks in 2017 and 2018 is available in the attached table.</p><p>The Code of Practice outlined in the Statistics and Registration Service Act 2007 prohibits the pre-release of official statistics before the due date of publication. Data on the number of legal abortions performed after 24 weeks in 2019 is still being collected and requires full quality assurance prior to release. Data for 2019 will be published on 11 June at 9:30am.</p><p> </p><p> </p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 27/03/2020 13:33:39 answering member 4527 label Biography information for Helen Whately attachment 1 file name PQ32115 table.xlsx title pq32115 table previous answer version 14441 answering member constituency Faversham and Mid Kent answering member printed Helen Whately answering member 4527 label Biography information for Helen Whately
tabling member	3958 label Biography information for Fiona Bruce